Ensysce Biosciences announced an updated investor presentation has been posted to the Company’s investor relations website. As a reminder, the Company will be holding a corporate update conference call today, Tuesday, April 11, 2023, at 11:00am ET.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ENSC:
- Ensysce Biosciences announces results from oral HAP trial for PF614
- Ensysce Biosciences reports Q4 EPS ($1.52), consensus ($2.41)
- Ensysce Biosciences, Inc. (ENSC) Q4 Earnings Cheat Sheet
- Ensysce Biosciences completes enrollment of PF614-MPAR-101 Phase 1 study
- Ensysce Biosciences announces database lock for HAP study of PF614
